VLA-4/VCAM-1 inhibitors (Theracrine)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameVLA-4/VCAM-1 inhibitors (Theracrine)
Drug Alias Namevery late antigen-4/vascular cell adhesion molecule-1 inhibitors (Theracrine)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionIntegrin alpha-4 inhibitorsVascular cell adhesion molecule 1 inhibitors
TargetsIntegrin alpha-4Vascular cell adhesion molecule 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheracrine Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheracrine Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A